Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-diethylaminopropiophenone
2. Amfepramon
3. Amfepramone
4. Anorex
5. Delgamer
6. Diethylpropion
7. Dietil Retard
8. Dietil-retard
9. Dietilretard
10. Hydrochloride, Diethylpropion
11. Ifa Norex
12. Lipomin
13. Maruate
14. Modratan
15. Neobes
16. Nobesine
17. Norex, Ifa
18. Phepranon
19. Prfamone
20. Propion
21. Regenon
22. Regibon
23. Tenuate
24. Tepanil
1. Amfepramone Hydrochloride
2. 134-80-5
3. Moderatan
4. Dobesin
5. Tenuate
6. Diethylpropion Hcl
7. Tepanil
8. Anorex
9. Tenuate Dospan
10. Regenon Hydrochloride
11. 2-(diethylamino)propiophenone Hydrochloride
12. Amfepramone (hydrochloride)
13. Prefamone
14. Regenon
15. Amphepramonum Hydrochloride
16. 1-propanone, 2-(diethylamino)-1-phenyl-, Hydrochloride
17. 19v2pl39ng
18. Diethylpropion Hydrochloride Civ
19. Alpha-benzoyltriethylammonium Chloride
20. Alpha-benzoyltriethylamine Hydrochloride
21. D03801
22. Diethylpropion Hydrochloride [usp]
23. Menutil
24. 1-phenyl-2-diethylaminopropanone-1 Hydrochloride
25. Magrex Retard
26. Tenuate-dospan
27. Amfepramon Hydrochloride
28. Lineal-rivo
29. Tepanil Ten-tab
30. Nu-dispoz
31. Dsstox_cid_27816
32. Dsstox_rid_82580
33. Dsstox_gsid_47838
34. Propiophenone, 2-(diethylamino)-, Hydrochloride
35. Diethylpropion Hydrochloride (usp)
36. 2-(diethylamino)-1-phenylpropan-1-one Hydrochloride
37. Cas-134-80-5
38. Chebi:643703
39. 2-diethylaminopropiophenone Hydrochloride
40. Sr-01000220674
41. Ncgc00167475-01
42. Einecs 205-156-5
43. Unii-19v2pl39ng
44. Tenuate (tn)
45. Rac Diethylpropion-d10 Hydrochloride
46. Diethylproion Hydrochloride
47. Cambridge Id 5809497
48. Chembl1693
49. Schembl15483
50. 2-(diethylamino)-1-phenyl-1-propanone Hydrochloride
51. 2-(diethylamino)-1-phenylpropan-1-one;hydrochloride
52. Dtxsid4047838
53. Hy-b0981
54. Tox21_112479
55. Akos015962206
56. Tox21_112479_1
57. Ccg-220122
58. Cs-4472
59. Diethylpropion Hydrochloride [mi]
60. Ncgc00167475-02
61. Ac-16025
62. Amfepramone Hydrochloride [who-dd]
63. As-16865
64. Diethylpropion Hydrochloride [mart.]
65. Diethylpropion Hydrochloride [vandf]
66. Diethylpropion Hydrochloride [usp-rs]
67. .alpha.-benzoyltriethylamine Hydrochloride
68. 090d846
69. Diethylpropion Hydrochloride [orange Book]
70. Diethylpropion Hydrochloride [usp Monograph]
71. Sr-01000220674-1
72. Sr-01000220674-2
73. Q27105182
74. Diethylpropion Hydrochloride Solution, 1.0 Mg/ml In Methanol (with 1% 1 M Hcl; As Free Base), Certified Reference Material
| Molecular Weight | 241.76 g/mol |
|---|---|
| Molecular Formula | C13H20ClNO |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 5 |
| Exact Mass | 241.1233420 g/mol |
| Monoisotopic Mass | 241.1233420 g/mol |
| Topological Polar Surface Area | 20.3 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 193 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 6 | |
|---|---|
| Drug Name | Diethylpropion hydrochloride |
| Active Ingredient | Diethylpropion hydrochloride |
| Dosage Form | Tablet, extended release; Tablet |
| Route | Oral |
| Strength | 75mg; 25mg |
| Market Status | Prescription |
| Company | Lannett Holdings; Corepharma; Avanthi |
| 2 of 6 | |
|---|---|
| Drug Name | Tenuate |
| Active Ingredient | Diethylpropion hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 25mg |
| Market Status | Prescription |
| Company | Watson Pharms |
| 3 of 6 | |
|---|---|
| Drug Name | Tenuate dospan |
| PubMed Health | Diethylpropion (By mouth) |
| Drug Classes | Appetite Suppressant, Centrally Acting |
| Drug Label | Diethylpropion hydrochloride, USPis available for oral administration in immediate-release tablets containing 25 mg diethylpropion hydrochloride. The inactive ingredients in each immediate-release tablet are: corn starch, lactose monohydrate, magne... |
| Active Ingredient | Diethylpropion hydrochloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 75mg |
| Market Status | Prescription |
| Company | Watson Pharms |
| 4 of 6 | |
|---|---|
| Drug Name | Diethylpropion hydrochloride |
| Active Ingredient | Diethylpropion hydrochloride |
| Dosage Form | Tablet, extended release; Tablet |
| Route | Oral |
| Strength | 75mg; 25mg |
| Market Status | Prescription |
| Company | Lannett Holdings; Corepharma; Avanthi |
| 5 of 6 | |
|---|---|
| Drug Name | Tenuate |
| Active Ingredient | Diethylpropion hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 25mg |
| Market Status | Prescription |
| Company | Watson Pharms |
| 6 of 6 | |
|---|---|
| Drug Name | Tenuate dospan |
| PubMed Health | Diethylpropion (By mouth) |
| Drug Classes | Appetite Suppressant, Centrally Acting |
| Drug Label | Diethylpropion hydrochloride, USPis available for oral administration in immediate-release tablets containing 25 mg diethylpropion hydrochloride. The inactive ingredients in each immediate-release tablet are: corn starch, lactose monohydrate, magne... |
| Active Ingredient | Diethylpropion hydrochloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 75mg |
| Market Status | Prescription |
| Company | Watson Pharms |
Appetite Depressants
Agents that are used to suppress appetite. (See all compounds classified as Appetite Depressants.)
API SUPPLIERS
Click Us!
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-10-10
Pay. Date : 2013-11-29
DMF Number : 2738
Submission : 1976-08-02
Status : Active
Type : II
NDC Package Code : 17337-0016
Start Marketing Date : 2012-12-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2008-02-05
Registration Number : 20080204-97-E-39-01
Manufacturer Name : Olon SpA
Manufacturer Address : Via Milano, 186 20024 Garbagnate Milanese (MI), Italy
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3437
Submission : 1978-11-30
Status : Active
Type : II
| Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2142
Submission : 1973-08-21
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2566
Submission : 1975-11-25
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5158
Submission : 1983-10-03
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 10920-600
Start Marketing Date : 2014-05-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0926
Start Marketing Date : 2014-08-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Registrant Name : Samhwa Biopharm Co., Ltd.
Registration Date : 2009-06-17
Registration Number : 20090617-97-E-84-02
Manufacturer Name : Samhwa Biopharm Co., Ltd.
Manufacturer Address : 150 Hyeop-ro, Siheung-si, Gyeonggi-do
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2142
Submission : 1973-08-21
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3437
Submission : 1978-11-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-10-10
Pay. Date : 2013-11-29
DMF Number : 2738
Submission : 1976-08-02
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2566
Submission : 1975-11-25
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5158
Submission : 1983-10-03
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RLD : No
TE Code :
Brand Name : TENUATE
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Approval Date : 1982-01-01
Application Number : 17668
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RLD : No
TE Code :
Brand Name : TENUATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 75MG
Approval Date : 1982-01-01
Application Number : 17669
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : DIETHYLPROPION HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Approval Date : 1982-01-01
Application Number : 85741
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
Brand Name : TENUATE DOSPAN
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-01-01
Application Number : 12546
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code : AA
Brand Name : DIETHYLPROPION HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Approval Date : 2010-12-22
Application Number : 201212
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
RLD : No
TE Code :
Brand Name : DIETHYLPROPION HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Approval Date : 1983-08-25
Application Number : 88267
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : DIETHYLPROPION HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Approval Date : 1983-08-25
Application Number : 88268
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL - 25MG **Federal Registe...DOSAGE - TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 11722
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 75MG...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 12546
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Capital Farma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Direct Compression
Disintegrants & Superdisintegrants
Granulation
Co-Processed Excipients
Thickeners and Stabilizers
Chewable & Orodispersible Aids
Solubilizers
Controlled & Modified Release
Taste Masking
Lubricants & Glidants
Parenteral
Coating Systems & Additives
Topical
Film Formers & Plasticizers
Rheology Modifiers
Vegetarian Capsules
API Stability Enhancers
Emulsifying Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
40
PharmaCompass offers a list of Diethylpropion Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diethylpropion Hydrochloride manufacturer or Diethylpropion Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diethylpropion Hydrochloride manufacturer or Diethylpropion Hydrochloride supplier.
PharmaCompass also assists you with knowing the Diethylpropion Hydrochloride API Price utilized in the formulation of products. Diethylpropion Hydrochloride API Price is not always fixed or binding as the Diethylpropion Hydrochloride Price is obtained through a variety of data sources. The Diethylpropion Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nobesine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nobesine, including repackagers and relabelers. The FDA regulates Nobesine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nobesine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nobesine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nobesine supplier is an individual or a company that provides Nobesine active pharmaceutical ingredient (API) or Nobesine finished formulations upon request. The Nobesine suppliers may include Nobesine API manufacturers, exporters, distributors and traders.
click here to find a list of Nobesine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nobesine DMF (Drug Master File) is a document detailing the whole manufacturing process of Nobesine active pharmaceutical ingredient (API) in detail. Different forms of Nobesine DMFs exist exist since differing nations have different regulations, such as Nobesine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Nobesine DMF submitted to regulatory agencies in the US is known as a USDMF. Nobesine USDMF includes data on Nobesine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nobesine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Nobesine suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nobesine Drug Master File in Korea (Nobesine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nobesine. The MFDS reviews the Nobesine KDMF as part of the drug registration process and uses the information provided in the Nobesine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nobesine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nobesine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nobesine suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nobesine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nobesine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nobesine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nobesine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nobesine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nobesine suppliers with NDC on PharmaCompass.
Nobesine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nobesine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nobesine GMP manufacturer or Nobesine GMP API supplier for your needs.
A Nobesine CoA (Certificate of Analysis) is a formal document that attests to Nobesine's compliance with Nobesine specifications and serves as a tool for batch-level quality control.
Nobesine CoA mostly includes findings from lab analyses of a specific batch. For each Nobesine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nobesine may be tested according to a variety of international standards, such as European Pharmacopoeia (Nobesine EP), Nobesine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nobesine USP).
